Comments on: Limitations of HPV DNA Testing in Screening of Cervical Adenocarcinomas

Segura, Marcos Emanuel de Alcântara

doi:10.1055/s-0039-1678591

Rev Bras Ginecol Obstet

2019

DOI: 10.1055/s-0039-1678591

|View full text |Cite

Comments on: Limitations of HPV DNA Testing in Screening of Cervical Adenocarcinomas

Marcos Emanuel de Alcântara Segura¹

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Dear Editor, We read with interest the article on human papillomavirus (HPV) DNA testing for cervical cancer in Brazil, authored by Zeferino et al (Brazilian Association for the Lower Genital Tract Pathology and Colposcopy (ABPTGIC, in the Portuguese acronym), as well as the subsequent letter to the editor, by Dr de Alcantara Segura, and the authors' reply. 1,2 We agree that detection of adenocarcinomas represents a significant challenge for cervical cancer screening programs. In the United States, squamous cancer rates have seen a decline since the introduction of the Pap smear and molecular testing, but adenocarcinoma rates have remained unchanged (►Fig.…”

mentioning

confidence: 65%